Newswise — Ann Arbor, Mich. – Physician-scientists worldwide are invited to apply for the 2015 Taubman Prize for Excellence in Translational Medical Science, the A. Alfred Taubman Medical Research Institute has announced.
The Taubman Prize, established in 2011, annually recognizes work in the crucial field of translational research – research that seeks to transform laboratory discoveries into clinical applications for patients suffering from disease. This is the mission of the Taubman Institute.
This global competition is open to all non-University of Michigan clinician-scientists. Nominations are due by Feb. 1, 2015.
The $100,000 award will be presented at the institute’s annual symposium in Ann Arbor on Oct. 16, 2015, to the clinician-scientist making the most significant contribution to translating basic research findings into medical practice. The awardee is expected to deliver the symposium’s keynote address.
“We are delighted to recognize our clinician-scientist colleagues worldwide, who share our mission of moving new cures and treatments swiftly from the lab to patients,” said Taubman Institute Director Eva Feldman, M.D., Ph.D. “We look forward to highlighting the work of another eminent researcher with the 2015 Taubman Prize and encourage physicians to submit their nominations.”
The 2014 awardee is Carl June, M.D., the Richard W. Vague Professor in Immunotherapy at the University of Pennsylvania’s Perelman School of Medicine, who presented the keynote address at the Taubman Institute’s annual symposium on October 10 at the University of Michigan.
A national panel of distinguished medical scientists selected him in recognition of his development of a novel treatment of leukemia using genetically engineered T cells, which is widely considered to be a breakthrough in treating blood cancers that have stopped responding to conventional therapies.
Nomination information is available at www.taubmaninstitute.org/taubmanprize. Entrants will be judged on their contribution to translating basic research findings into clinical applications and by the manner in which their clinical practice connects to their research.
About the A. Alfred Taubman Medical Research Institute: In 2007 Michigan businessman and philanthropist A. Alfred Taubman provided the initial funds to establish the institute bearing his name at the University of Michigan Medical School. Its mission is to provide the university’s finest medical scientists the freedom, resources and collaborative environment they need to push the boundaries of medical discovery, to produce breakthroughs in cures to speed the development of effective treatment for some of the most devastating illnesses.
RSS